Damora Therapeutics, Inc. · NASDAQ:DMRA
Fairmount Funds Management LLC reported a 19.99% stake in Damora Therapeutics, Inc. (Schedule 13D)
Event Nov 10, 2025 · Filed Nov 17, 2025
Fairmount Funds Management LLC reported a 19.99% stake in Damora Therapeutics, Inc., 397,000 shares, with active intent on Nov 10, 2025. Filed Nov 17, 2025 (Schedule 13D).
- Stake
- 19.99%
- Shares
- 397,000
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fairmount Funds Management LLC | 19.99% | 397,000 |
| Fairmount Healthcare Fund II L.P. | 19.99% | 397,000 |
| Fairmount Healthcare Co-Invest V L.P. | 19.99% | 397,000 |
| Peter Evan Harwin | 19.99% | 397,000 |
| Tomas Kiselak | 19.99% | 397,000 |
Source
Related
- Damora Therapeutics, Inc.
- Fairmount Funds Management LLC
- Damora Therapeutics, Inc. shareholders
- Schedule 13D/A · Fairmount Funds Management LLC · Feb 11, 2026
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026